Dharini Mudgal

'Chandni Chowk market hit by ₹300-400 crore loss since Delhi blast,' says BJP MP

Delhi's Chandni Chowk market has suffered losses of around ₹300–400 crore following the terror attack near the Red Fort, BJP MP Praveen Khandelwal said. He added that retail footfall has dropped as police have imposed restrictions following the blast. Chandni Chowk sees a footfall of at least 4 lakh people daily and is the country's largest wholesale market, News18 reported.

Nov 13th, 2025

'Chandni Chowk market hit by ₹300-400 crore loss since Delhi blast,' says BJP MP

Roshan Gupta

In a move to shake up Dalal Street, Univest aims to dismantle the old investing hierarchy by giving retail investors pro-level guidance—which stock to buy, when to buy, and when to sell—for just ₹1. Univest shared that a market veteran called it "the most transparent reform yet," and social media called it "the Bitcoin moment for Indian equities!"

Nov 13th, 2025

Retail Stock Investors now competing with Sharks: Univest

Arshiya Chopra

A monthly mutual funds investment of ₹3,000 for 10 years will give a maturity corpus of ₹6.72 lakh at an annual growth rate of 12%. Meanwhile, investing ₹3 lakh lump sum in mutual funds for 10 years will give ₹9.32-lakh maturity corpus. NDTV Profit stated SIPs suit cautious investors while lump sum investments are for high risk takers.

Nov 13th, 2025

What is better, ₹3,000 SIP or ₹3 lakh lump sum?

Founded by Vimal Kumar and Sheetal Lalwani, Bengaluru-based fintech Juspay posted a ₹62 crore net profit in FY25, reversing last year’s loss, as revenue rose 48% to ₹514 crore. Backed by SoftBank, Accel, and Kedaara Capital, the company now handles about $1 trillion in annualised payment value and powers 20 UPI apps including Google Pay.

Nov 12th, 2025

Juspay posts ₹62 crore  profit, revenue hits ₹514 crore

Stanley Lifestyles posted H1 FY26 revenue of ₹2,141 million, up 5.1 % year-on-year. Gross margins rose to 57.8% (up 330 bps), while EBITDA increased 22.5 % to ₹473 million with margins at 22.1 % (up 320 bps). Profit after tax jumped 45.3 % to ₹138 million, driven by improved efficiency and cost control.

Nov 12th, 2025

Stanley Lifestyles posts 45% PAT rise, 22.5% EBITDA jump

FES Cafe, India’s first 100 % egg-less dessert-led cafe chain, has raised about $1 million in a Pre-Series A round led by 12 Flags, with participation from Wolfpack Labs. The funds will be used to expand across Delhi–NCR, build a central production kitchen to boost delivery operations, and hire leadership talent for its next growth phase.

Nov 12th, 2025

FES Cafe raises $1 mn in Pre-Series A round

Ishita Ranganath

Skims, founded by reality TV and social media star Kim Kardashian and Jens Grede, announced it had raised $225 million in new capital, valuing the company at $5 billion, adding $200 million to Kardashian's fortune. Skims expects to surpass $1 billion in net sales in 2025, stated Bloomberg. A 2023 funding round valued the company at $4 billion.

Nov 12th, 2025

Kim Kardashian's Skims raises new funding, reaches $5-bn valuation

Garima Garg

PIB's fact-check unit dismissed a media report claiming that India is planning to provide financial incentives to airlines for operating flights at dormant airports to revive them. "This...is...fake, baseless, and factually incorrect. No such proposal is under consideration by the government," PIB said. Reports claimed airlines would be offered monthly subsidy payments in return for cheaper fares.

Nov 12th, 2025

PIB dismisses report on India's plan to revive dormant airports

Coinbase (COIN) said it will leave Delaware and reincorporate in Texas, citing unpredictable outcomes from Delaware Chancery Court. Chief Legal Officer Paul Grewal said Texas offers better governance flexibility and legal predictability. COIN shares rose over 2% pre-market as retail sentiment on Stocktwits trended bullish.

Nov 12th, 2025

Coinbase leaves Delaware for Texas citing legal uncertainty

Cormedix (CRMD) shares jumped 8% pre-market after Q3 results topped estimates, and the company raised full-year revenue guidance to $390–$410 million. The strong performance was fueled by higher DefenCath use among dialysis patients. EPS came in at $1.26, doubling expectations, with 2025 EBITDA projected between $220–$240 million.

Nov 12th, 2025

Cormedix stock soars on Q3 beat and raised 2025 outlook

Popular BizShortz


Recommended Topics

© yugma 2025

Google Play and the Google Play logo are trademarks of Google LLC.

Apple and the Apple logo are trademarks of Apple Inc.